miR-34a inhibits Prostate Cancer Stem Cells
January 17th, 2011
No comments
Researchers have demonstrated that miR-34a inhibits prostate cancer tumor-initiating cells by suppressing CD44, a cell surface protein prevalent on cancer cells. Read more…
Categories: miR-34a, Mirna Therapeutics, Prostate Cancer, Stem Cell Technology
